| Antisense oligonucleotides: an emerging area in drug discovery and development K Dhuri, C Bechtold, E Quijano, H Pham, A Gupta, A Vikram, R Bahal Journal of clinical medicine 9 (6), 2004, 2020 | 443 | 2020 |
| In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery R Bahal, N Ali McNeer, E Quijano, Y Liu, P Sulkowski, A Turchick, YC Lu, ... Nature communications 7 (1), 13304, 2016 | 180 | 2016 |
| In utero nanoparticle delivery for site-specific genome editing AS Ricciardi, R Bahal, JS Farrelly, E Quijano, AH Bianchi, VL Luks, ... Nature communications 9 (1), 2481, 2018 | 160 | 2018 |
| Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium NA McNeer, K Anandalingam, RJ Fields, C Caputo, S Kopic, A Gupta, ... Nature communications 6 (1), 6952, 2015 | 159 | 2015 |
| Focus: genome editing: therapeutic peptide nucleic acids: principles, limitations, and opportunities E Quijano, R Bahal, A Ricciardi, WM Saltzman, PM Glazer The Yale journal of biology and medicine 90 (4), 583, 2017 | 112 | 2017 |
| Surface modified poly (β amino ester)-containing nanoparticles for plasmid DNA delivery RJ Fields, CJ Cheng, E Quijano, C Weller, N Kristofik, N Duong, ... Journal of controlled release 164 (1), 41-48, 2012 | 109 | 2012 |
| Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue JK Saucier-Sawyer, Y Deng, YE Seo, CJ Cheng, J Zhang, E Quijano, ... Journal of drug targeting 23 (7-8), 736-749, 2015 | 100 | 2015 |
| Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors JK Saucier-Sawyer, YE Seo, A Gaudin, E Quijano, E Song, AJ Sawyer, ... Journal of Controlled Release 232, 103-112, 2016 | 92 | 2016 |
| Peptide nucleic acids as a tool for site-specific gene editing AS Ricciardi, E Quijano, R Putman, WM Saltzman, PM Glazer Molecules 23 (3), 632, 2018 | 71 | 2018 |
| Anti-tumor activity of miniPEG-γ-modified PNAs to inhibit microRNA-210 for cancer therapy A Gupta, E Quijano, Y Liu, R Bahal, SE Scanlon, E Song, WC Hsieh, ... Molecular Therapy-Nucleic Acids 9, 111-119, 2017 | 70 | 2017 |
| Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir M Mohideen, E Quijano, E Song, Y Deng, G Panse, W Zhang, MR Clark, ... Biomaterials 144, 144-154, 2017 | 68 | 2017 |
| Optimizing biodegradable nanoparticle size for tissue-specific delivery HK Mandl, E Quijano, HW Suh, E Sparago, S Oeck, M Grun, PM Glazer, ... Journal of Controlled Release 314, 92-101, 2019 | 61 | 2019 |
| Peptide nucleic acids and gene editing: perspectives on structure and repair NG Economos, S Oyaghire, E Quijano, AS Ricciardi, WM Saltzman, ... Molecules 25 (3), 735, 2020 | 56 | 2020 |
| Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition R Bahal, E Quijano, N A McNeer, Y Liu, D C Bhunia, F Lopez-Giraldez, ... Current gene therapy 14 (5), 331-342, 2014 | 53 | 2014 |
| Modified poly (lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung RJ Fields, E Quijano, NA McNeer, C Caputo, R Bahal, K Anandalingam, ... Advanced healthcare materials 4 (3), 361, 2014 | 42 | 2014 |
| From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection SN Kudalkar, J Beloor, E Quijano, KA Spasov, WG Lee, JA Cisneros, ... Proceedings of the National Academy of Sciences 115 (4), E802-E811, 2018 | 36 | 2018 |
| Direct targeting of amplified gene loci for proapoptotic anticancer therapy M Kaushik Tiwari, DA Colon-Rios, HCR Tumu, Y Liu, E Quijano, ... Nature Biotechnology 40 (3), 325-334, 2022 | 24 | 2022 |
| Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium MH Kural, J Wang, L Gui, Y Yuan, G Li, KL Leiby, E Quijano, G Tellides, ... Biomaterials 212, 28-38, 2019 | 24 | 2019 |
| Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV SN Kudalkar, I Ullah, N Bertoletti, HK Mandl, JA Cisneros, J Beloor, ... Antiviral research 167, 110-116, 2019 | 19 | 2019 |
| Compositions for enhancing targeted gene editing and methods of use thereof WM Saltzman, P Glazer, R Bahal, NA McNeer, E Quijano US Patent 11,136,597, 2021 | 17 | 2021 |
W. Mark SaltzmanProfessor of Biomedical Engineering, Yale UniversityAdresse e-mail validée de yale.edu